The last time we saw today's setup, one group of stocks more than doubled in four years and left U.S. stocks in the dust... It has nothing to do with China. And it might surprise you... European stocks are now dirt-cheap compared with their U.S. counterparts. Based on histo
Three initial public offerings (IPOs) on last week’s calendar made it out the door and there are four new IPOs on this week’s list.
Among last week’s IPOs, Chinese-education company Bright Scholar Education Holdings Ltd. (NYSE: BEDU) sold 15 million shares at $10.50, above the expected range of $8 to $10 and raised $158 million. The first-day pop rang in at 28% and the stock....More>>>
Blue-chip companies rightfully make up the bulk of most people’s investment portfolios. These large-cap firms possess considerable industry leverage, as well as a vast sum of financial resources. Their status and importance to the underlying economy means that they are the least likely to crumble, regardless of external pressures. Ultimately, blue chips provide the confidence and stability....More>>>
Smith & Wesson Holding Corp. (NASDAQ: SWHC) reported fiscal second-quarter financial results after markets closed on Thursday. The company said that it had $0.68 in earnings per share (EPS) and $233.5 million in revenue, versus consensus estimates from Thomson Reuters called for $0.56 in EPS and $227.61 million in revenue. The same period from last year had $0.25 in EPS and $143.24 million in....More>>>
John Buckingham, editor of The Prudent Speculator, focuses on a widely-diversified portfolio of value-oriented stocks; here, he reviews two leading pharmaceutical firms with promising drug development operations.
Biogen discovers, develops and delivers innovative therapies for the treatment of neurodegenerative diseases and autoimmune disorders.
As top Republicans see it, a medical malpractice crisis is threatening U.S. health care: Frivolous lawsuits are driving up malpractice insurance premiums and forcing physicians out of business. Doctors and hospitals live in fear of litigation, ordering excessive tests and treatments that make health care unaffordable for Americans.
That’s why Republican House Speaker Paul Ryan and....More>>>
Sales Trends A Bit Soft, But Nothing To Worry About
I have been a bit disappointed by Nordstroms (NYSE:JWN) recent results. Not because it was a bad quarter per se, but because it broke the sequence of constant overperformance compared to other peers in the
It's been a bad month for Pegasystems (NASDAQ: PEGA), with investors running for the exits after a huge top-line miss in Q3. For an enterprise software company, there's probably nothing worse. Pegasystems sold off from all-time highs near $65 and now trades nearly 20% lower, in the low $50s.
I have previously written some articles where I have tracked Tesla's (NASDAQ:TSLA) construction and purchases of property, plant, and equipment (P,P & E), as well as Tesla's payments for them. The reason Tesla does not have to pay for all its equipment up front was explained in
Ever since the proposed acquisition of Rite Aid Corporation (NYSE:RAD) by Walgreens Boots Alliance Inc (NASDAQ:WBA) was restructured multiple times and eventually turned into an all-cash deal for a couple stores, RAD stock has been left for dead.